{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:25:41Z","timestamp":1786119941231,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/aci.0b013e32834877ab","type":"journal-article","created":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T05:48:14Z","timestamp":1307512094000},"page":"332-336","source":"Crossref","is-referenced-by-count":10,"title":["Insect anaphylaxis"],"prefix":"10.1097","volume":"11","author":[{"given":"James M.","family":"Tracy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Demain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210128","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","article-title":"Risk assessment in anaphylaxis: current and future approaches.","volume":"l20","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R3-11-20210128","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJM199208063270603","article-title":"Fatal and near-fatal anaphylactic reactions to food in children and adolescents.","volume":"327","author":"Sampson","year":"1992","journal-title":"N Engl J Med"},{"key":"R4-11-20210128","first-page":"1166","article-title":"Anaphylaxis epidemic: fact or fiction J Allergy Clin I","volume":"122","author":"Simons","year":"2008","journal-title":"mmunol"},{"key":"R5-11-20210128","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2011.01.025","article-title":"Stinging insect hypersensitivity: a practice parameter update 2011.","volume":"127","author":"Golden","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R6-11-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0091-6749(84)90397-X","article-title":"Insect venom allergy: diagnosis and treatment.","volume":"73","author":"Valentine","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"R7-11-20210128","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJM197807272990401","article-title":"A controlled trial of immunotherapy in insect hypersensitivity.","volume":"299","author":"Hunt","year":"1978","journal-title":"N Engl J Med"},{"key":"R8-11-20210128","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0091-6749(92)90304-K","article-title":"Venom immunotherapy: 10 years of experience with administration of single venoms and 50 micrograms maintenance doses.","volume":"89","author":"Reisman","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"R9-11-20210128","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1067\/mai.2001.115042","article-title":"Insect sting allergy: the dilemma of the negative skin test reactor.","volume":"107","author":"Reisman","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R10-11-20210128","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1067\/mai.2001.114706","article-title":"Insect allergy with negative venom skin tests.","volume":"107","author":"Golden","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"R11-11-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0091-6749(03)01537-9","article-title":"Negative venom skin test results in patients with histories of systemic reaction to a sting (Rostrum article).","volume":"112","author":"Golden","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R12-11-20210128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"key":"R13-11-20210128","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.","volume":"124","author":"Rueff","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R14-11-20210128","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels.","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R15-11-20210128","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1398-9995.2009.02108.x","article-title":"How much specific is the association between hymenoptera venom allergy and mastocytosis A","volume":"64","author":"Bonadonna","year":"2009","journal-title":"llergy"},{"key":"R16-11-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1398-9995.2010.02470.x","article-title":"Influence of total specific IgE, serum tryptase, and age on severity of allergic reactions to Hymenoptera stings.","volume":"66","author":"Blum","year":"2011","journal-title":"Allergy"},{"key":"R17-11-20210128","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1398-9995.2009.02302.x","article-title":"Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly.","volume":"65","author":"Guenova","year":"2010","journal-title":"Allergy"},{"key":"R18-11-20210128","first-page":"34","article-title":"Anaphylaxis and mast cell disease: what is the risk Curr Allergy Asthma R","volume":"10","author":"Akin","year":"2010","journal-title":"ep"},{"key":"R19-11-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2010.04.025","article-title":"Predictors of side effects during build-up phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase.","volume":"126","author":"Rueff","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"R20-11-20210128","first-page":"11","article-title":"Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis.","volume":"100","author":"Oude Elberink","year":"1997","journal-title":"J Allergy Clin Immunol"},{"key":"R21-11-20210128","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/ACI.0b013e32833b280c","article-title":"Mastocytosis and insect venom allergy.","volume":"10","author":"Bonadonna","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R22-11-20210128","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1398-9995.2009.02118.x","article-title":"Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy.","volume":"64","author":"Niedoszytko","year":"2009","journal-title":"Allergy"},{"key":"R24-11-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000312634","article-title":"The angiotensinogen AGT p.M235T gene polymorphism may be responsible for the development of severe anaphylactic reactions to insect venom allergens.","volume":"153","author":"Niedoszytko","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"R26-11-20210128","first-page":"119","article-title":"Genetic aspect of venom allergy: association with HLA class I and class II antigens.","volume":"17","author":"Karakis","year":"2010","journal-title":"Ann Agric Environ Med"},{"key":"R27-11-20210128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-0030-1268430","article-title":"Basophil activation test for the diagnosis of hymenoptera venom allergy in childhood: a pilot study.","volume":"223","author":"Ott","year":"2011","journal-title":"Klin Padiatr"},{"key":"R28-11-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1710-1492-5-11","article-title":"Importance of basophil activation testing in insect venom allergy.","volume":"5","author":"Kosnik","year":"2011","journal-title":"Allergy Asthma Clin Immunol"},{"key":"R29-11-20210128","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1365-2222.2009.03347.x","article-title":"Basophil responsiveness in patients with insect sting allergies and negative venom-specific immunoglobulin E and skin prick test results.","volume":"39","author":"Kruse","year":"2009","journal-title":"Clinical Exp Allergy"},{"key":"R30-11-20210128","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s00508-009-1174-y","article-title":"Diagnostic value of the basophil activation test in evaluating Hymenoptera venom sensitization.","volume":"121","author":"Peternelj","year":"2009","journal-title":"Wien Klin Wochenschr"},{"key":"R31-11-20210128","first-page":"110","article-title":"Basophil activation can predict clinical sensitivity in patients after venom immunotherapy.","volume":"20","author":"Kucera","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R32-11-20210128","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/cyto.b.20142","article-title":"Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.","volume":"72","author":"Ebo","year":"2007","journal-title":"Cytometry B Clin Cytom"},{"key":"R33-11-20210128","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1398-9995.2004.00624.x","article-title":"The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.","volume":"59","author":"Erdmann","year":"2004","journal-title":"Allergy"},{"key":"R34-11-20210128","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jaci.2007.01.008","article-title":"Expression of activation markers on basophils in a controlled model of anaphylaxis.","volume":"119","author":"Gober","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R35-11-20210128","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1398-9995.2007.01604.x","article-title":"High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent mastocytosis.","volume":"63","author":"Kontou-Fili","year":"2008","journal-title":"Allergy"},{"key":"R36-11-20210128","first-page":"225","article-title":"Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab.","volume":"19","author":"Galera","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R37-11-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.anai.2010.04.011","article-title":"Omalizumab monotherapy for bee sting and unprovoked anaphylaxis in a patient with systemic mastocytosis and undetectable specific IgE.","volume":"104","author":"Kontou-Fill","year":"2010","journal-title":"Ann All Asthma Immunol"},{"key":"R38-11-20210128","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1398-9995.2009.02259.x","article-title":"Omalizumab is effective in treating systemic mastocytosis in a nonatopic patient.","volume":"65","author":"Douglass","year":"2009","journal-title":"Allergy"},{"key":"R39-11-20210128","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.anai.2010.05.004","article-title":"Multiple epinephrine doses for stinging insect hypersensitivity reactions treated in the emergency department.","volume":"105","author":"Rudders","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R40-11-20210128","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/ACI.0b013e32833a6c72","article-title":"Anaphylaxis and insect allergy.","volume":"10","author":"Demain","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R41-11-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2009.03.050","article-title":"Anaphylaxis in the community: learning from the survivors.","volume":"124","author":"Simons","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"R42-11-20210128","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.anai.2010.11.005","article-title":"Risk factors for systemic reactions to bee venom in British beekeepers.","volume":"106","author":"Richter","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R43-11-20210128","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jaci.2008.04.031","article-title":"Use of multiple doses of epinephrine in food-induced anaphylaxis in children.","volume":"122","author":"Jarvinen","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"R44-11-20210128","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1081-1206(10)60358-4","article-title":"Factors associated with repeated use of epinephrine for the treatment of anaphylaxis.","volume":"103","author":"Manivannan","year":"2009","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Current Opinion in Allergy & Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/ACI.0b013e32834877ab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:32:27Z","timestamp":1786044747000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130832-201108000-00011"}},"subtitle":["addressing clinical challenges"],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aci.0b013e32834877ab","relation":{},"ISSN":["1528-4050"],"issn-type":[{"value":"1528-4050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}